Searchable abstracts of presentations at key conferences in endocrinology

ea0065p13 | Adrenal and Cardiovascular | SFEBES2019

Seasonal vaccination and associated steroid management practice in adrenal insufficiency

O'Murchadha Liam , Dib Liana , Hannon Anne Marie , Dineen Rosemary , Garrahy Aoife , Thompson CJ , Fitzpatrick Fidelma , Sherlock Mark

Background: Adrenal insufficiency remains a potentially life-threatening condition, necessitating adequate glucocorticoid replacement and appropriate stress-related adjustment to avoid crisis. Flu-like illness is a key precipitant of adrenal crisis. While some authorities recommend annual influenza vaccination for such patients, uptake rates in this population are unknown. Additionally, while seasonal vaccines may lead to minor symptoms in the general population, there are no ...

ea0049ep487 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Lipoprotein particle size in women with type 1 diabetes mellitus and its relationship to carotid intima-media thickness

Gunness Anjuli , Ahmed Mohamed , Pazderska Agnieska , Phelan Niamh , Moore Kevin , Boran Gerard , Behan Lucy-Ann , Sherlock Mark , Gibney James

Although cardiovascular disease (CVD) is greatly increased in type 1 diabetes mellitus (T1DM), patients typically have apparently healthy lipid profiles. Simple measurement of plasma lipids however does not provide information regarding lipoprotein particle size which in the nondiabetic population is independently predictive of CVD. Plasma lipids and lipoprotein subclasses (using polyacrylamide gel-tube electrophoresis) were studied in reproductive age women with T1DM and comp...

ea0041ep877 | Pituitary - Clinical | ECE2016

“The incidence of central adrenal insufficiency in euvolaemic hyponatraemia. Results of a large prospective study”

Cuesta Martin , Slattery David , Garrahy Aoife , Hannon Anne Marie , Tatro Elizabeth , Gupta Saket , Sherlock Mark , Tormey William , Thompson Christopher J

Context: The syndrome of inappropriate antidiuresis(SIAD) is the commonest cause of hyponatraemia. Data on the aetiology of SIAD is mainly derived from retrospective studies, often with poor ascertainment of minimum criteria for correct diagnosis. Although central adrenal insufficiency(CAI) is known to cause euvolaemic hyponatraemia, the incidence of undiagnosed CAI in SIAD is unknown.Objective: To establish the incidence of CAI in SIAD.<p class="abs...

ea0059p135 | Neuroendocrinology and pituitary | SFEBES2018

Bolus 3% saline restores cognitive function more rapidly than traditional slow intravenous infusion of 3% saline in the emergency treatment of SIAD, with symptoms of cerebral irritation

Garrahy Aoife , Dineen Rosemary , Hannon Anne Marie , Zia-ul-Hussnain HM , Cuesta Martin , Sherlock Mark , Thompson Chris

Acute hyponatraemia is a medical emergency with high mortality. Recent expert guidelines advocate treatment with intravenous boluses of 3% saline with the aim to reduce cerebral oedema more rapidly than traditional slow intravenous infusion, but there is a poor evidence base for this policy change. We retrospectively audited treatment of symptomatic hyponatraemia due to SIAD (n=57, age 22–76 year), comparing low dose (20 ml/h) and bolus infusion of 3% saline. Bol...

ea0037oc12.1 | Pituitary – Clinical | ECE2015

The Irish TSHoma study: a multicentre retrospective study

Pazderska Agnieszka , Cuesta Martin , Wallace Helen , Melvin Audrey , Gibney James , Agha Amar , O'Halloran Donal , Hunter Steven , Thompson Chris , Sherlock Mark

TSH-secreting pituitary adenomas (TSHomas) are rare. Previously, the reported prevalence was one case per million populations although this is probably an underestimate. A recently published study reported a prevalence of TSHomas in Sweden of 2.8/million inhabitants.Methods/design: Observational study conducted in four tertiary referral centres in Ireland. We retrospectively collected data on the prevalence, demographics, hormonal profile, tumour charact...

ea0037gp.19.05 | Pituitary–Acromegaly | ECE2015

Clinical and biochemical outcomes during pregnancy in patients with acromegaly

O'Shea Triona , Guptha Saket , Melvin Audrey , McGurran Karen , Casey Ruth , O'Halloran Donal , Gibney James , Thompson Christopher , Sherlock Mark

Acromegaly is a rare condition resulting from excess secretion of GH and IGF1. Acromegaly is frequently associated with subfertility. As such there is little data on the course of the disease during pregnancy, and of the effects of the disease and its treatments on the foetus.Objective: We describe known pregnancies in women with acromegaly within the Republic of Ireland over a 15-year period.Methods: We collected clinical, biochem...

ea0037ep196 | Reproduction, endocrine disruptors and signalling | ECE2015

Endocrinopathies associated with lithium therapy in an Irish tertiary referral centre

Dineen Rosemary , Bogdanet Delia , Thompson C J , Thompson D , Boran Gerard , Gibney James , Keane Veronica , Sherlock Mark

Lithium is used in psychiatric practice as maintenance therapy in bipolar disorder. It has a narrow therapeutic index with serious toxic potential. Lithium is associated with multiple endocrine and metabolic disturbances but data regarding the rates of these in individual patients is lacking. In a tertiary referral centre, all patients on lithium therapy from 2000 to 2014 were identified. The aim of this study was to assess the impact of lithium therapy on the development of e...

ea0031p74 | Clinical practice/governance and case reports | SFEBES2013

Spironolactone interference in the immunoassay of androstenedione in a patient with a cortisol-secreting adrenal adenoma

Broderick Deirdre , Crowley Rachel K , O'Shea Triona , Boran Gerard , Conlon Kevin , Maher Vincent , Gibney James , Sherlock Mark

A 48-year-old man was referred for investigation of uncontrolled hypertension on four agents (olmesartan, felodipine, hydrochlorothiazide and spironolactone) and a 3 cm right-sided adrenal adenoma (pre-contrast Hounsfield units 25). Endocrine investigation for the hypertension and adrenal mass included: androstenedione 19.9 nmol/l 2.8–10.5) (elevated on two occasions on a Siemens Coat-A-Count assay), DHEA 0.7 μmol/l (2.1–15.2), 1 mg overnight dexamethasone suppr...

ea0031p220 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Hepatic 11β-hydroxysteroid dehydrogenase type 1 is elevated following weight loss secondary to bariatric surgery

Woods Conor , Taylor Angela , Hughes Beverly , Corrigan Michelle , Stewart Paul , Tomlinson Jeremy , Shea Donal O , Sherlock Mark

In the pathogenesis of obesity, dysregulated tissue cortisol metabolism (controlled by 11β-HSD1), is postulated to be involved. Fifteen patients (seven mens, mean BMI 50.8±7 kg/m2) awaiting Roux En Y gastric Bypass (RYGB) surgery underwent assessment of 11β-HSD1 activity using cortisol generation profile. Corticosteroids in serum and subcutaneous adipose tissue microdialysis fluid and urinary corticosteroid metabolites were analysed by liquid and gas ...

ea0015p258 | Pituitary | SFEBES2008

Monitoring acromegaly disease activity with growth hormone and insulin like growth factor-I in 501 patients

Sherlock Mark , Alonso Aurora Aragon , Ayuk John , Clayton Richard N , Sheppard Michael C , Bates Andy , Stewart Paul

The aim of treatment in patients with acromegaly is to achieve serum GH/ IGF-I concentrations associated with cure or normalisation of mortality. Using the West Midlands acromegaly database (n=501) we assessed a number of parameters in the follow up of patients with acromegaly including the reliability of basal fasting GH in predicting nadir or mean GH during oral glucose tolerance test (OGTT) or growth hormone day curve (GHDC) respectively, the degree of discordance be...